212 related articles for article (PubMed ID: 26449252)
1. Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
Zhang Y; Pan KF; Zhang L; Ma JL; Zhou T; Li JY; Shen L; You WC
Carcinogenesis; 2015 Dec; 36(12):1572-9. PubMed ID: 26449252
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
3. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH
J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680
[TBL] [Abstract][Full Text] [Related]
4. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
5. Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions.
Zhang LJ; Wang SY; Huo XH; Zhu ZL; Chu JK; Ma JC; Cui DS; Gu P; Zhao ZR; Wang MW; Yu J
World J Gastroenterol; 2009 Jun; 15(22):2731-8. PubMed ID: 19522023
[TBL] [Abstract][Full Text] [Related]
6. Alterations of Cyclooxygenase-2 Methylation Levels Before and After Intervention Trial to Prevent Gastric Cancer in a Chinese Population.
Zhang Y; Zeng HM; Nie XR; Zhang L; Ma JL; Li JY; Pan KF; You WC
Cancer Prev Res (Phila); 2016 Jun; 9(6):484-90. PubMed ID: 27020655
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
[TBL] [Abstract][Full Text] [Related]
9. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients.
Sheu BS; Yang HB; Sheu SM; Huang AH; Wu JJ
Clin Cancer Res; 2003 Nov; 9(14):5245-51. PubMed ID: 14614005
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions.
Sung JJ; Leung WK; Go MY; To KF; Cheng AS; Ng EK; Chan FK
Am J Pathol; 2000 Sep; 157(3):729-35. PubMed ID: 10980112
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis.
Shao Y; Sun K; Xu W; Li XL; Shen H; Sun WH
World J Gastroenterol; 2014 Sep; 20(36):12860-73. PubMed ID: 25278683
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
Correa P; Fontham ET; Bravo JC; Bravo LE; Ruiz B; Zarama G; Realpe JL; Malcom GT; Li D; Johnson WD; Mera R
J Natl Cancer Inst; 2000 Dec; 92(23):1881-8. PubMed ID: 11106679
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study.
Dong CX; Deng DJ; Pan KF; Zhang L; Zhang Y; Zhou J; You WC
Int J Cancer; 2009 Jan; 124(2):434-9. PubMed ID: 18821580
[TBL] [Abstract][Full Text] [Related]
14. A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication.
Pan KF; Zhang L; Gerhard M; Ma JL; Liu WD; Ulm K; Wang JX; Zhang L; Zhang Y; Bajbouj M; Zhang LF; Li M; Vieth M; Liu RY; Quante M; Wang LH; Suchanek S; Zhou T; Guan WX; Schmid R; Classen M; You WC
Gut; 2016 Jan; 65(1):9-18. PubMed ID: 25986943
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
[TBL] [Abstract][Full Text] [Related]
16. [Prophylactic effect of a selective COX-2 inhibitor celecoxib on carcinogen-induced gastric premalignant lesions in rats].
Tang BD; Zeng ZR; Hu PJ
Ai Zheng; 2006 Oct; 25(10):1205-9. PubMed ID: 17059761
[TBL] [Abstract][Full Text] [Related]
17. Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.
He C; Kong F; Zhu X; Kong F; Zhao W; Liu Y; Wang K
Biomed Res Int; 2021; 2021():4171019. PubMed ID: 34888378
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).
Miehlke S; Kirsch C; Dragosics B; Gschwantler M; Oberhuber G; Antos D; Dite P; Läuter J; Labenz J; Leodolter A; Malfertheiner P; Neubauer A; Ehninger G; Stolte M; Bayerdörffer E
World J Gastroenterol; 2001 Apr; 7(2):243-7. PubMed ID: 11819768
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data.
Muñoz N; Vivas J; Buiatti E; Kato I; Oliver W
IARC Sci Publ; 1996; (139):125-33. PubMed ID: 8923024
[TBL] [Abstract][Full Text] [Related]
20. The long-term effect of Helicobacter pylori eradication on COX-1/2, 5-LOX and leukotriene receptors in patients with a risk gastritis phenotype--a link to gastric carcinogenesis.
Venerito M; Kuester D; Wex T; Roessner A; Malfertheiner P; Treiber G
Cancer Lett; 2008 Nov; 270(2):218-28. PubMed ID: 18571838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
